A recent study has identified the variation in the ADAM33 gene as an important risk factor for asthma. This is not only good news for asthma sufferers, suggesting new directions for diagnostics and treatment, but also provides encouragement that unravelling the genetics of common diseases may not be quite as hard as had been feared. When a variant has a frequency difference between cases and controls, there are two possible explanations. First, it may be a real effect. That is, the variant is either a risk factor or in linkage disequilibrium with a risk factor. The second possibility, however, is that the frequency difference results from cryptic population stratification. If the cases and controls are drawn from subpopulations that have differences in disease incidence, then any marker showing an allele frequency difference between the subpopulations will show an allele frequency difference between the cases and the controls. One solution to this problem is to use familybased controls, as for example in the transmission disequilibrium class of tests [6] which use parental chromosomes as controls, opposed to those from randomly selected healthy individuals. Eederwegh et al.
Asthma is a common, complex, autoimmune disorder [1] which is estimated to affect about 155 million individuals worldwide. Along with its associated clinical phenotypes, asthma has been under vigorous genetic investigation for many years. Like most other common diseases, the genetics of asthma has been investigated using both family-based and population based approaches [2] . Up until now, the results have been largely disappointing, highlighting the difficult task faced by researchers trying to unravel the genetic architecture of multifactorial diseases such as asthma, diabetes, hypertension and the neuropsychiatric conditions. But now Van Eerdewegh et al. [3] have identified a gene, ADAM33, which seems to be an important risk factor in asthma and bronchial hyperresponsiveness. They took a sequential approach to the problem ( Figure  1 ). Using a coarse set of highly variable genetic markers -microsatellites -spaced approximately every 10 cM throughout the genome, they first assessed the sharing of marker alleles in affected sib pairs. Under the null model of no physical linkage to disease-causing alleles, affected siblings are expected to share half their alleles at a marker locus. Markers linked to disease causing alleles, however, are expected to show an excess of allele sharing between affected sibs.
In their affected sib analysis, Van Eerdewegh et al. To pinpoint the risk factors within this long stretch of genomic sequence, Eederwegh et al. [3] turned to an association study. The basic approach used in an association study is straightforward. To test whether a single nucleotide polymorphism (SNP) is associated with a disease -either directly because it itself is causal, or indirectly because it is in linkage disequilibrium [4] with one or more other causative polymorphisms -allele frequencies can be compared in affected (cases) and unaffected (controls) using simple statistical tools. The prospects for fine localization are improved because instead of depending on the recombination events within a pedigree, as must be done in a linkage study, association studies capitalize on recombination events that have taken place over many generations within a population.
Using the rough draft of the human genome [5] as reference and a combination of molecular sequencing strategies, Eederwegh et al. [3] characterised 40 genes of which 23 were selected as potential candidate genes to focus the selection of SNP identification. These 23 genes were deemed as candidates based on potential function, relevant tissue expression (lung), and physical location with respect to the peak logarithm of odds (LOD) score -the quantitative measure of the probability that the observed linkage is significant. Altogether 135 single nucleotide polymorphisms were identified, genotyped and used in tests of association. Twenty-four single nucleotide polymorphisms showed significant association with asthma and bronchial hyperresponsiveness.
When a variant has a frequency difference between cases and controls, there are two possible explanations. First, it may be a real effect. That is, the variant is either a risk factor or in linkage disequilibrium with a risk factor. The second possibility, however, is that the frequency difference results from cryptic population stratification. If the cases and controls are drawn from subpopulations that have differences in disease incidence, then any marker showing an allele frequency difference between the subpopulations will show an allele frequency difference between the cases and the controls. One solution to this problem is to use familybased controls, as for example in the transmission disequilibrium class of tests [6] which use parental chromosomes as controls, opposed to those from randomly selected healthy individuals. Eederwegh et al. [3] show that the association observed in the casecontrol comparison was also observed in a transmission disequilibrium test, ruling out spurious association due to population stratification.
The majority of the positive associations occurred in the gene ADAM33. Haplotypes were then constructed and their frequencies compared in tests of association. In all cases, much greater significance was observed for haplotypes versus individual SNPs. ADAM33 is a member of a family of genes that encode proteins with proteolytic activity and that are primarily expressed in lung fibroblasts and bronchial smooth muscle. Thus ADAM33 now joins a very small list of genes that have been identified as common disease risk factors through population based gene mapping, including calpain-10, a risk factor for type 2 diabetes mellitus [6] , and NOD2, a risk factor for Crohn's disease [7, 8] .
The difficulty researchers have encountered in mapping genes for multifactorial diseases are not surprising. There are many reasons to be pessimistic. We still know extremely little about the genetics of common diseases, and as has been extensively discussed recently, the details of genetic causation will determine the success of linkage disequilibrium-based mapping efforts. Perhaps the most important questions concern the frequency of variants influencing common diseases. The utility of the genome-wide characterization of linkage disequilibrium envisioned in the HapMap project [9] will depend on the applicability of the 'common disease-common variant' framework which postulates that the alleles conferring susceptibility to common diseases are themselves common and generally found in multiple human populations [10] . If the causal mutations have low frequencies, however, as has been observed in some cases [8, 10] and predicted by at least some theoretical analyses ([11] for example, but see also [12] which reaches the opposite conclusion), then association approaches, as they are normally now implemented, will not be effective.
A related, but distinguishable, question is the extent of genetic heterogeneity [13] . It is well known that the allelic spectrum underlying single locus disorders is relatively diverse, that is, many different alleles at a single locus cause disease. If the spectra for common diseases turned out to be similarly diverse, then association approaches will again be suboptimal. Another layer of complexity is introduced by our ignorance of patterns of linkage disequilibrium in human populations [14] . Finally, the definition of disease itself can introduce serious problems. Disease state can serve as an ill-defined phenotype for genetic analysis, as the distinction between health and disease, which involves a multitude of underlying pathophysiological activities, is often ignored. This can make the predictability of the disease by its underlying genes weak, resulting in unrealistic sample size requirements.
The new study by Eedewegh et al. [3] however, offers reassurance on most of these points. Firstly, through the use of intermediate, quantitative phenotypes in conjunction with disease end-points, the authors added significant statistical power to their study, as such phenotypes potentially represent genetically and environmentally more homogenous correlates for putative disease causing alleles [15] . This point is exemplified by the more significant maximum LOD score from the results of the scan that included asthma plus bronchial hyperresponsiveness, as opposed to the asthma-only linkage scans, even though the sample size for the asthma-only scan was nearly double that of the other scan. This result should encourage human geneticists to move beyond the disease-event focus of early association studies.
Secondly, the genome region encompassing the ADAM33 gene has many of the characteristics required to be suitable for linkage disequilibriumdependent association mapping, and also conforms nicely to the common disease-common variant framework as a working model. For example, contrary to the findings for NOD2 [7] , in the case for Crohn's disease, the ADAM33 gene variants that increase (Figure 1) proves that linkage and association approaches can be fruitfully combined without having to resort to the currently expensive and time-consuming genome-wide association mapping of complex diseases. And finally, this study lends further support to the 'candidate-gene' approach for studying complex traits and highlights the fact that biological insight into disease pathophysiology and common-sense prioritisation provides us with two valuable tools with which a considerable amount of time and cost can be saved [16] .
Two other points deserve further discussion. First, while the extent of useful linkage disequilibrium [17] around ADAM33 might be higher than usual, it is unlikely that reduced linkage disequilibrium will impose a real constraint on linkage disequilibrium-based gene mapping. Recent evidence suggests that, as long as the causal variants are common, tagging SNPs can be identified that will represent most of the variation in a target region -such as in the linkage implicated region studied here -or within candidate genes [18] . There would just need to be a larger or smaller set of tagging SNPs depending on the local extent of linkage disequilibrium. Finally, it is interesting to note that some of the SNPs in significant association with asthma and bronchial hyperresponsiveness are located in non-coding regions including introns and 3′ ′ untranslated regions. This highlights the importance of characterising genetic variation in regulatory as well as coding gene segments [19] , and argues against an 'exons first' approach to association studies [20] .
